Atlanta Braves Holdings, Inc. (BATRA) insider details RSU vesting

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. executive vice president of development reported equity award activity involving Series C Common Stock (BATRK). On December 11, 2025, 11,142 restricted stock units converted into an equal number of shares at $0, bringing direct holdings to 250,467 shares. On December 12, 2025, 4,874 shares were sold at a weighted average price of $39.74 to cover tax withholding tied to the vesting, leaving 245,593 shares held directly. The report also notes 55,503 shares held indirectly through a grantor retained annuity trust and 11,142 restricted stock units outstanding, with the remaining units scheduled to vest on December 11, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Plant Michael P.

(Last) (First) (Middle)

C/O ATLANTA BRAVES HOLDINGS, INC.

755 BATTERY AVENUE SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Atlanta Braves Holdings, Inc. [ BATRK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Development

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series C Common Stock	12/11/2025		M		11,142	A	$0(1)	250,467	D
Series C Common Stock	12/12/2025		S(2)		4,874	D	$39.74(3)	245,593	D
Series C Common Stock								55,503	I	By Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units - BATRK	(4)	12/11/2025		M			11,142	(5)	(5)	Series C Common Stock	11,142	$0	11,142	D

Explanation of Responses:

1. Each restricted stock unit converted into one share of Series C Common Stock.

2. The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

3. Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

4. Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

5. One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

	/s/ Kerry T. Wenzel, Attorney-in-Fact	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Atlanta Braves Holdings, Inc. (BATRA) report?

An executive vice president of development reported the vesting of restricted stock units into Series C Common Stock and a related sale of shares to cover tax withholding obligations.

How many Atlanta Braves Holdings Series C shares vested on December 11, 2025?

On December 11, 2025, 11,142 restricted stock units converted into an equal number of Series C Common Stock shares at an exercise price of $0.

How many Atlanta Braves Holdings shares were sold and at what price?

On December 12, 2025, the officer sold 4,874 shares of Series C Common Stock at a weighted average price of $39.74 per share to cover tax withholding obligations.

How many Atlanta Braves Holdings Series C shares does the insider own after the transactions?

Following the reported transactions, the officer holds 245,593 shares of Series C Common Stock directly and 55,503 shares indirectly through a grantor retained annuity trust.

What restricted stock units remain outstanding for the Atlanta Braves Holdings executive?

The filing shows 11,142 restricted stock units outstanding, each representing a contingent right to receive one share of Series C Common Stock.

What is the vesting schedule for the executive’s restricted stock units at Atlanta Braves Holdings?

One-third of the restricted stock unit award vested on each of December 11, 2024 and December 11, 2025, and the remaining units are scheduled to vest on December 11, 2026.